Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
Kedudukan dalam Saham #17922
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
Harga Saham
$18.20
Disegerakkan terakhir: 2025-05-09
Modal Pasaran
$220.35M
Perubahan (1 hari)
-5.34%
Perubahan (1 tahun)
0.00%
Negara
JP
Perdagangan I'rom Group Co., Ltd. (2372)

Kategori

Pendapatan untuk I'rom Group Co., Ltd. (2372)
Pendapatan pada Dec 2024 TTM: $9.98M
Menurut laporan kewangan terkini I'rom Group Co., Ltd., pendapatan semasa syarikat ialah $9.98M. Pada tahun 2023, syarikat memperoleh pendapatan sebanyak $25.17M, peningkatan berbanding pendapatan pada tahun 2022 yang berjumlah $21.24M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi I'rom Group Co., Ltd. dari 2005 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $9.98M -23.16%
2024 $12.99M -48.39%
2023 $25.17M 18.51%
2022 $21.24M 39.44%
2021 $15.23M 45.30%
2020 $10.48M -1.23%
2019 $10.61M -38.18%
2018 $17.17M 595.33%
2017 $2.47M -134.25%
2016 $-7.21M 43.61%
2015 $-5.02M 55.00%
2014 $-3.24M -117.10%
2013 $18.94M -1,247.10%
2012 $-1.65M -227.92%
2011 $1.29M -117.79%
2010 $-7.26M -93.02%
2009 $-104.01M 912.86%
2008 $-10.27M 79.68%
2007 $-5.72M -184.52%
2006 $6.76M -56.10%
2005 $15.40M 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$9.87B 98,800.88%
US
- -
DE
$687.82M 6,791.50%
SA
$3.87B 38,624.74%
US
- -
MY